4.2 Article

Medication management and adherence during the COVID-19 pandemic: Perspectives and experiences from low-and middle-income countries

Journal

RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY
Volume 17, Issue 1, Pages 2023-2026

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.sapharm.2020.04.007

Keywords

COVID-19; Chronic diseases; Medication adherence; Community pharmacists; Pharmaceutical care; LMICs

Ask authors/readers for more resources

The current COVID-19 pandemic is straining health systems worldwide, particularly affecting patients with chronic illnesses who may struggle to access routine care. Community pharmacists in retail outlets play a crucial role in managing chronic conditions and promoting medication adherence, supporting the World Health Organization's call to maintain essential services to prevent non-COVID disease burden on healthcare systems.
The current coronavirus disease 2019 (COVID-19) pandemic is placing a huge strain on health systems worldwide. Suggested solutions like social distancing and lockdowns in some areas to help contain the spread of the virus may affect special patient populations like those with chronic illnesses who are unable to access healthcare facilities for their routine care and medicines management. Retail pharmacy outlets are the likely facilities for easy access by these patients. The contribution of community pharmacists in these facilities to manage chronic conditions and promote medication adherence during this COVID-19 pandemic will be essential in easing the burden on already strained health systems. This paper highlights the pharmaceutical care practices of community pharmacists for patients with chronic diseases during this pandemic. This would provide support for the call by the WHO to maintain essential services during the pandemic, in order to prevent non-COVID disease burden on healthcare systems particularly in low-and middle-income countries.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available